Fundz

Evoke Pharma Appoints Matthew J. D’Onofrio as Chief Executive Officer

PRIVATEMar 21, 2024

Position

Founder

Company

Evoke Pharma

Matthew J. D’Onofrio
mdonofrio@evokepharma.com
Solana BeachBiotechnologyHealth CarePharmaceutical

Description

Evoke Pharma, Inc announces the appointment of Matthew J. D’Onofrio as the new Chief Executive Officer. Mr D’Onofrio will be taking over the role on March 31, 2024, upon Mr Gonyer's departure for personal reasons.

Quick answer

Evoke Pharma Appoints Matthew J. D’Onofrio as Chief Executive Officer (March 21, 2024). Evoke Pharma is based in Solana Beach, California, United States.

Who is the new Founder at Evoke Pharma?
Evoke Pharma named Matthew J. D’Onofrio Founder, announced March 21, 2024.
What did Evoke Pharma announce on March 21, 2024?
Evoke Pharma, Inc announces the appointment of Matthew J. D’Onofrio as the new Chief Executive Officer. Mr D’Onofrio will be taking over the role on March 31, 2024, upon Mr Gonyer's departure for personal reasons.
What does Evoke Pharma do?
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal spray.
Where is Evoke Pharma based?
Evoke Pharma is based in Solana Beach, California, United States.
Which similar companies made leadership changes around the same time?
Lifecore Biomedical (March 20, 2024), Conduit Pharmaceuticals Limited (March 19, 2024), Fulcrum Therapeutics (March 18, 2024) and Oragenics (March 18, 2024) also announced leadership changes within 45 days of Evoke Pharma.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Evoke Pharma, and when

A new leader at Evoke Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Evoke Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evoke Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evoke Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Evoke Pharma

Location

Solana Beach, California, United States

About

Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal spray. The company developed, commercialized and markets GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Evoke Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Matthew
Likely contact at this company
••••••••@••••••••

See Matthew's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Evoke Pharma's next move

Learn about Strategic plan

Evoke Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.